-
Study aim
-
The effect of ephedrine, ketamine, ondansetron and atropine on nausea and vomiting during and after surgery under spinal anesthesia.
-
Design
-
Clinical trial, with parallel groups, double-blind, randomized, phase 2-3 on 128 patients, the patients were randomized based on the block random pattern.
-
Settings and conduct
-
Patients are hospitalized for at least one day before surgery and will fast for 8 hours. Upon entering the operating room, an intravenous line is established for the patient and through it they receive 10 ml per kg of Ringer's serum. Before the spinal anesthesia, the patients will receive 4 groups of medicine. In order to equalize the volume of intervention medicine in all groups, after calculating the desired dose, it will be brought to 5 ml with distilled water and administered intravenously. The frequency and severity of nausea and vomiting, the degree of sedation and the amount of metoclopyramide will be recorded by the student. The study will be designed in a double-blind manner.The patient, the data recorder, and the analyst will not know about the grouping.
-
Participants/Inclusion and exclusion criteria
-
Inclusion cditeria: age 18-75 years ohd; both genders; ASA class 1 and 2; lower limb fracture repair surgery under spinal anesthesia. Failure to enter: history of drug addiction; history of allergies: neuromuscular diseases: cardiomyopathy: coagulation disease: underlying disease.
-
Intervention groups
-
Group 1: 5 mg of ephedrine. Group 2: 100 micrograms of atropine. Group 3: 8 mg of ondansetron. Group 4: Ketamine at the rate of 0.3 mg per kg
-
Main outcome variables
-
Vomiting score in recovery, 2, 4, 6, 12, and 24 hours after surgery
Occurrence of nausea during recovery, 2, 4, 6, 12, and 24 hours after surgery.
Severity of nausea during recovery, 2, 4, 6, 12, and 24 hours after surgery
RAMSAY score in recovery and 1, 2 and 4 hours after the operation
Taking Metoclopyramide within 24 hours